Rydex Biotechnology Fund Class H (RYOAX)

Fund Assets	123.77M
Expense Ratio	1.65%
Min. Investment	$2,500
Turnover	75.00%
Dividend (ttm)	n/a
Dividend Yield	n/a
Dividend Growth	n/a
Payout Frequency	n/a
Ex-Dividend Date	Dec 16, 2025

Previous Close	76.02
YTD Return	30.63%
1-Year Return	60.13%
5-Year Return	42.71%
52-Week Low	55.49
52-Week High	76.28
Beta (5Y)	0.88
Holdings	73
Inception Date	Apr 1, 1998

About RYOAX

Rydex Biotechnology Fund Class H is a mutual fund designed to seek capital appreciation by investing primarily in companies within the biotechnology industry. The fund typically allocates at least 80% of its net assets to equity securities issued by biotechnology firms, which are engaged in research, development, manufacturing, and distribution of various biotechnological products and services. This focus positions the fund to capture growth opportunities in sectors such as pharmaceuticals, medical devices, and advancements in genetic engineering. Managed by Security Investors, LLC, the fund utilizes a team-managed approach and targets exposure across both established and emerging biotechnology companies. Its annual distribution frequency and active management make it a specialized vehicle for investors seeking focused access to the innovation-driven biotech market, which plays an increasingly vital role in healthcare and medical advancements. Notably, the fund maintains a higher expense ratio compared to broad market funds, reflecting the specialized expertise and research intensity required in this sector.

• Fund Family: Rydex Funds
• Category: Health
• Performance Rating: Above Average
• Risk Rating: Average
• Stock Exchange: NASDAQ
• Ticker Symbol: RYOAX
• Share Class: Class H
• Index: S&P 500 TR

Performance

RYOAX had a total return of 60.13% in the past year, including dividends. Since the fund's inception, the average annual return has been 10.86%.

Equivalent Funds

These are funds that follow the same index from the other major fund companies.

Symbol	Provider	Name	Expense Ratio
FIKCX	Fidelity	Fidelity Advisor Health Care Z	0.56%
FSPHX	Fidelity	Fidelity Select Health Care Portfolio	0.62%
FIJYX	Fidelity	Fidelity Advisor Biotechnology Z	0.58%
FSHCX	Fidelity	Fidelity Select Health Care Services Portfolio	0.67%
FBTAX	Fidelity	Fidelity Advisor Biotechnology A	0.96%

Other Share Classes

These are alternative share classes of the same fund, from the same provider.

Symbol	Share Class	Expense Ratio
RYOIX	Investor Class	1.40%
RYBOX	Class A	1.65%
RYCFX	Class C	2.40%

Top 10 Holdings

36.17% of assets

Name	Symbol	Weight
AbbVie Inc.	ABBV	8.15%
Amgen Inc.	AMGN	5.04%
Gilead Sciences, Inc.	GILD	4.48%
Vertex Pharmaceuticals Incorporated	VRTX	4.31%
Regeneron Pharmaceuticals, Inc.	REGN	2.93%
Revolution Medicines, Inc.	RVMD	2.47%
Alnylam Pharmaceuticals, Inc.	ALNY	2.35%
BeOne Medicines AG	ONC	2.17%
Moderna, Inc.	MRNA	2.14%
Biogen Inc.	BIIB	2.12%

Dividend History

Ex-Dividend	Amount	Pay Date
Dec 16, 2025	$9.40578	Dec 16, 2025
Dec 12, 2024	$9.42277	Dec 12, 2024
Dec 20, 2022	$0.89943	Dec 20, 2022
Dec 8, 2021	$15.77303	Dec 8, 2021
Dec 9, 2020	$6.95038	Dec 9, 2020
Dec 10, 2019	$3.60206	Dec 10, 2019

Data Sources: Tiingo, Twelve Data, and more

Historical data is provided by Tiingo. Delayed stock pricing data is provided by Twelve Data. Several fund data points are also provided by Finnhub.

Last checked:

Aug 27, 2026

Data Sources Report a data error